Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal’s Health CareBOM:544350 +0.12%17 Pretax Margin % is 13.58% as of Mar. 2026, which is 45% above its 10-year median of 9.34. GuruFocus rates BOM:544350 with a GF Score™ of 17/100. The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Dr Agarwal’s Health Care ranks better than 71.81% on this metric.
The historical rank and industry rank for Dr Agarwal’s Health Care's Pretax Margin % or its related term are showing as below:
BOM:544350'
s Pretax Margin % Range Over the Past 10 Years
Min: 8.16 Med: 9.34 Max: 11.95
Current: 11.95
BOM:544350's Pretax Margin % is ranked better than 71.81% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs BOM:544350: 11.95
Dr Agarwal’s Health Care (BOM:544350) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Dr Agarwal’s Health Care Pretax Margin % Related Terms
Dr Agarwal’s Health Care Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544350 vs ISRG, BDX, MDLN: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, Dr Agarwal’s Health Care's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal’s Health Care Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dr Agarwal’s Health Care's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Dr Agarwal’s Health Care's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal’s Health Care (BOM:544350) has a Pretax Margin % of 13.58% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Dr Agarwal’s Health Care and its competitors. This is 45% above median its historical median of 9.34. Over the past decade, Dr Agarwal’s Health Care's Pretax Margin % has ranged from 8.16 to 11.95. According to the industry distribution chart, Dr Agarwal’s Health Care ranks #230 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 28.2%.
Is Dr Agarwal’s Health Care's Pretax Margin % too high?
Dr Agarwal’s Health Care's current Pretax Margin % of 13.58% is 45% above median its 10-year median of 9.34. Over the past 10 years, this metric has ranged from a low of 8.16 to a high of 11.95. The Medical Devices & Instruments industry median Pretax Margin % is 2.31. Dr Agarwal’s Health Care's value of 13.58% is 487.9% above this industry median. Based on the distribution chart, Dr Agarwal’s Health Care ranks #230 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dr Agarwal’s Health Care has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal’s Health Care's Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Dr Agarwal’s Health Care ranks #230 out of 816 companies for Pretax Margin %. This puts Dr Agarwal’s Health Care in the upper half of its industry. The industry median Pretax Margin % is 2.31. Dr Agarwal’s Health Care's value of 13.58% is 487.9% above this benchmark. Historically, Dr Agarwal’s Health Care's own Pretax Margin % has ranged from 8.16 to 11.95 over the past decade. While the company's 10-year median is 9.34 vs. the industry median of 2.31, Dr Agarwal’s Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.31, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal’s Health Care's current Pretax Margin % of 13.58% is 487.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Dr Agarwal’s Health Care and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal’s Health Care's current Pretax Margin % is 13.58%, which is 45% above median its own 10-year median of 9.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal’s Health Care stock overvalued right now?
Dr Agarwal’s Health Care (BOM:544350) has a current Pretax Margin % of 13.58%. The current Pretax Margin % is 13.58%, which is 45% above median its 10-year median of 9.34 and 487.9% above the Medical Devices & Instruments industry median of 2.31. Dr Agarwal’s Health Care's overall GF Score™ is 17/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Dr Agarwal’s Health Care (BOM:544350), the current Pretax Margin % is 13.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dr Agarwal's Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa. It generates maximum revenue from India.
17GF Score
Get the complete analysis for BOM:544350
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544350 has been successfully added to your 
